Johannes Wedel, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dopamine | 7 | 2016 | 1607 | 1.130 |
Why?
|
| Aortic Diseases | 2 | 2016 | 735 | 0.690 |
Why?
|
| Transplantation | 1 | 2019 | 219 | 0.590 |
Why?
|
| Organ Transplantation | 3 | 2022 | 1157 | 0.570 |
Why?
|
| Graft Rejection | 5 | 2018 | 4446 | 0.570 |
Why?
|
| Infusion Pumps, Implantable | 2 | 2016 | 158 | 0.570 |
Why?
|
| Amidohydrolases | 1 | 2016 | 159 | 0.510 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2016 | 699 | 0.480 |
Why?
|
| Endocannabinoids | 1 | 2014 | 111 | 0.450 |
Why?
|
| Capsaicin | 1 | 2014 | 231 | 0.450 |
Why?
|
| Aorta, Abdominal | 1 | 2016 | 625 | 0.440 |
Why?
|
| Jugular Veins | 1 | 2014 | 210 | 0.420 |
Why?
|
| Skin Transplantation | 1 | 2018 | 1083 | 0.420 |
Why?
|
| G1 Phase | 1 | 2014 | 403 | 0.420 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2016 | 1492 | 0.410 |
Why?
|
| Graft Survival | 4 | 2018 | 3820 | 0.400 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2021 | 4369 | 0.350 |
Why?
|
| Catheterization, Central Venous | 1 | 2014 | 526 | 0.330 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2022 | 2872 | 0.330 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2019 | 2898 | 0.320 |
Why?
|
| Immune Tolerance | 1 | 2017 | 2302 | 0.290 |
Why?
|
| Heart Transplantation | 2 | 2018 | 3233 | 0.280 |
Why?
|
| Rats, Inbred BN | 2 | 2016 | 231 | 0.270 |
Why?
|
| Mitochondria | 1 | 2019 | 3624 | 0.260 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2016 | 1809 | 0.260 |
Why?
|
| Enzyme Inhibitors | 1 | 2016 | 3713 | 0.250 |
Why?
|
| Neointima | 2 | 2016 | 133 | 0.250 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2018 | 3080 | 0.240 |
Why?
|
| Lymphocyte Activation | 1 | 2014 | 5485 | 0.220 |
Why?
|
| Chemotaxis, Leukocyte | 2 | 2016 | 662 | 0.210 |
Why?
|
| Drug Delivery Systems | 1 | 2014 | 2226 | 0.210 |
Why?
|
| T-Lymphocytes | 3 | 2021 | 10194 | 0.190 |
Why?
|
| Immunosuppressive Agents | 1 | 2014 | 4176 | 0.190 |
Why?
|
| Mice, Inbred BALB C | 2 | 2019 | 6214 | 0.170 |
Why?
|
| Cells, Cultured | 5 | 2021 | 18966 | 0.170 |
Why?
|
| Cell Proliferation | 5 | 2019 | 10451 | 0.160 |
Why?
|
| Apoptosis | 6 | 2022 | 9490 | 0.160 |
Why?
|
| Transplantation, Homologous | 2 | 2018 | 4807 | 0.160 |
Why?
|
| Mice, Inbred C3H | 1 | 2018 | 915 | 0.140 |
Why?
|
| Adoptive Transfer | 1 | 2019 | 819 | 0.140 |
Why?
|
| Phosphorylation | 3 | 2018 | 8321 | 0.140 |
Why?
|
| Ergocalciferols | 1 | 2017 | 110 | 0.130 |
Why?
|
| Endothelial Cells | 4 | 2021 | 3549 | 0.130 |
Why?
|
| Lymphangiogenesis | 1 | 2017 | 172 | 0.130 |
Why?
|
| Methylation | 1 | 2018 | 1084 | 0.130 |
Why?
|
| Cytoprotection | 1 | 2016 | 200 | 0.120 |
Why?
|
| Signal Transduction | 2 | 2016 | 23447 | 0.120 |
Why?
|
| Animals | 12 | 2022 | 168475 | 0.120 |
Why?
|
| GPI-Linked Proteins | 1 | 2016 | 470 | 0.120 |
Why?
|
| Receptors, Calcitriol | 1 | 2017 | 360 | 0.120 |
Why?
|
| Cyclohexanones | 1 | 2014 | 30 | 0.120 |
Why?
|
| Transcription Factors | 1 | 2014 | 12130 | 0.120 |
Why?
|
| Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 1 | 2014 | 93 | 0.120 |
Why?
|
| Receptor-CD3 Complex, Antigen, T-Cell | 1 | 2014 | 67 | 0.120 |
Why?
|
| Iron Compounds | 1 | 2014 | 28 | 0.120 |
Why?
|
| ZAP-70 Protein-Tyrosine Kinase | 1 | 2014 | 69 | 0.120 |
Why?
|
| Role | 1 | 2014 | 176 | 0.120 |
Why?
|
| Rats, Wistar | 2 | 2017 | 1848 | 0.120 |
Why?
|
| Proteinuria | 1 | 2017 | 607 | 0.110 |
Why?
|
| Glutathione | 1 | 2016 | 583 | 0.110 |
Why?
|
| Coordination Complexes | 1 | 2014 | 73 | 0.110 |
Why?
|
| Nerve Growth Factors | 1 | 2016 | 564 | 0.110 |
Why?
|
| Transcription Factor AP-1 | 1 | 2014 | 321 | 0.100 |
Why?
|
| Lymphatic Vessels | 1 | 2017 | 358 | 0.100 |
Why?
|
| Transplantation Immunology | 1 | 2014 | 532 | 0.100 |
Why?
|
| Transcription Factor RelA | 1 | 2013 | 254 | 0.100 |
Why?
|
| Unfolded Protein Response | 1 | 2014 | 234 | 0.100 |
Why?
|
| Anserine | 1 | 2010 | 2 | 0.090 |
Why?
|
| Carnosine | 1 | 2010 | 6 | 0.090 |
Why?
|
| NF-kappa B | 3 | 2014 | 2490 | 0.090 |
Why?
|
| Macrophages | 2 | 2016 | 5767 | 0.090 |
Why?
|
| Forkhead Transcription Factors | 1 | 2018 | 1616 | 0.090 |
Why?
|
| Dipeptidases | 1 | 2010 | 38 | 0.090 |
Why?
|
| Carbon Monoxide | 1 | 2014 | 547 | 0.090 |
Why?
|
| Microvessels | 1 | 2015 | 577 | 0.090 |
Why?
|
| TRPV Cation Channels | 1 | 2012 | 244 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 2 | 2019 | 22174 | 0.090 |
Why?
|
| Drug Synergism | 1 | 2014 | 1757 | 0.090 |
Why?
|
| Histidine | 1 | 2010 | 308 | 0.080 |
Why?
|
| Kidney Transplantation | 2 | 2015 | 4235 | 0.080 |
Why?
|
| Serine | 1 | 2013 | 831 | 0.080 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2014 | 1334 | 0.080 |
Why?
|
| Actins | 1 | 2016 | 2050 | 0.080 |
Why?
|
| Oxidation-Reduction | 1 | 2014 | 2231 | 0.070 |
Why?
|
| Aorta | 1 | 2016 | 2041 | 0.070 |
Why?
|
| Adenosine Triphosphate | 1 | 2014 | 1989 | 0.070 |
Why?
|
| Cell Cycle | 1 | 2016 | 2932 | 0.070 |
Why?
|
| Immunologic Memory | 1 | 2014 | 1359 | 0.070 |
Why?
|
| Inflammation Mediators | 1 | 2016 | 1886 | 0.070 |
Why?
|
| Receptors, Cell Surface | 1 | 2016 | 2822 | 0.070 |
Why?
|
| Oxygen | 1 | 2018 | 4227 | 0.070 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 3 | 2014 | 691 | 0.070 |
Why?
|
| Cell Division | 1 | 2014 | 4465 | 0.070 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2021 | 3246 | 0.070 |
Why?
|
| Killer Cells, Natural | 1 | 2016 | 2201 | 0.070 |
Why?
|
| Glucose | 1 | 2018 | 4347 | 0.070 |
Why?
|
| Mice | 5 | 2022 | 81539 | 0.070 |
Why?
|
| Reactive Oxygen Species | 1 | 2014 | 2139 | 0.070 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2014 | 1974 | 0.070 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2016 | 2805 | 0.070 |
Why?
|
| Time Factors | 3 | 2016 | 39969 | 0.060 |
Why?
|
| Mice, Transgenic | 1 | 2018 | 9542 | 0.060 |
Why?
|
| Kidney Neoplasms | 1 | 2022 | 4251 | 0.060 |
Why?
|
| Mice, Knockout | 1 | 2019 | 14417 | 0.060 |
Why?
|
| Rats | 3 | 2017 | 23741 | 0.060 |
Why?
|
| Gene Expression Regulation | 4 | 2015 | 11904 | 0.060 |
Why?
|
| Tumor Microenvironment | 1 | 2017 | 3878 | 0.060 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2013 | 2273 | 0.050 |
Why?
|
| Kidney | 2 | 2017 | 7048 | 0.050 |
Why?
|
| Vitamin D | 1 | 2017 | 3303 | 0.050 |
Why?
|
| Chronic Disease | 2 | 2015 | 9319 | 0.050 |
Why?
|
| Oxidative Stress | 1 | 2014 | 3113 | 0.050 |
Why?
|
| Male | 7 | 2019 | 360846 | 0.050 |
Why?
|
| Mevalonic Acid | 1 | 2021 | 46 | 0.050 |
Why?
|
| Blood Platelets | 1 | 2012 | 2479 | 0.050 |
Why?
|
| Lignans | 1 | 2022 | 84 | 0.050 |
Why?
|
| Humans | 15 | 2022 | 761596 | 0.050 |
Why?
|
| Acute Kidney Injury | 1 | 2012 | 1924 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2014 | 14665 | 0.040 |
Why?
|
| Simvastatin | 1 | 2021 | 346 | 0.040 |
Why?
|
| Biphenyl Compounds | 1 | 2022 | 1007 | 0.040 |
Why?
|
| Blotting, Western | 2 | 2016 | 5035 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2016 | 18255 | 0.030 |
Why?
|
| Sirolimus | 1 | 2022 | 1533 | 0.030 |
Why?
|
| Inflammation | 1 | 2014 | 10774 | 0.030 |
Why?
|
| Autophagy | 1 | 2022 | 1327 | 0.030 |
Why?
|
| Receptors, Fibrinogen | 1 | 2012 | 1 | 0.030 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2022 | 2057 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2014 | 4352 | 0.030 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2012 | 293 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2016 | 2467 | 0.020 |
Why?
|
| Cell Degranulation | 1 | 2012 | 277 | 0.020 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2014 | 373 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2016 | 2626 | 0.020 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2014 | 598 | 0.020 |
Why?
|
| Doxorubicin | 1 | 2017 | 2224 | 0.020 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2016 | 803 | 0.020 |
Why?
|
| Ganglia, Spinal | 1 | 2012 | 526 | 0.020 |
Why?
|
| Platelet Aggregation | 1 | 2012 | 771 | 0.020 |
Why?
|
| Peripheral Nerves | 1 | 2012 | 479 | 0.020 |
Why?
|
| Cyclic AMP | 1 | 2012 | 1463 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2017 | 3430 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2013 | 3088 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2013 | 1844 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2013 | 2919 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2016 | 5870 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2022 | 16990 | 0.020 |
Why?
|
| Cell Movement | 1 | 2017 | 5205 | 0.020 |
Why?
|
| Cell Survival | 1 | 2014 | 5791 | 0.010 |
Why?
|
| Gene Expression | 1 | 2017 | 7581 | 0.010 |
Why?
|
| Phenotype | 1 | 2021 | 16592 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2012 | 6075 | 0.010 |
Why?
|
| Liver Cirrhosis | 1 | 2010 | 1935 | 0.010 |
Why?
|
| MicroRNAs | 1 | 2015 | 3816 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 11076 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2014 | 9420 | 0.010 |
Why?
|
| Female | 2 | 2014 | 392705 | 0.010 |
Why?
|
| Neurons | 1 | 2012 | 9463 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2015 | 64685 | 0.000 |
Why?
|
| Risk Factors | 1 | 2015 | 74213 | 0.000 |
Why?
|
| Young Adult | 1 | 2010 | 59260 | 0.000 |
Why?
|
| Middle Aged | 1 | 2010 | 220921 | 0.000 |
Why?
|
| Adult | 1 | 2010 | 221210 | 0.000 |
Why?
|